1. Home
  2. CELZ vs IMCC Comparison

CELZ vs IMCC Comparison

Compare CELZ & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELZ
  • IMCC
  • Stock Information
  • Founded
  • CELZ 1998
  • IMCC 1980
  • Country
  • CELZ United States
  • IMCC Israel
  • Employees
  • CELZ N/A
  • IMCC N/A
  • Industry
  • CELZ Biotechnology: Pharmaceutical Preparations
  • IMCC Medicinal Chemicals and Botanical Products
  • Sector
  • CELZ Health Care
  • IMCC Health Care
  • Exchange
  • CELZ Nasdaq
  • IMCC Nasdaq
  • Market Cap
  • CELZ 5.5M
  • IMCC 5.3M
  • IPO Year
  • CELZ N/A
  • IMCC N/A
  • Fundamental
  • Price
  • CELZ $2.18
  • IMCC $6.20
  • Analyst Decision
  • CELZ
  • IMCC
  • Analyst Count
  • CELZ 0
  • IMCC 0
  • Target Price
  • CELZ N/A
  • IMCC N/A
  • AVG Volume (30 Days)
  • CELZ 30.8K
  • IMCC 351.3K
  • Earning Date
  • CELZ 05-09-2025
  • IMCC 05-15-2025
  • Dividend Yield
  • CELZ N/A
  • IMCC N/A
  • EPS Growth
  • CELZ N/A
  • IMCC N/A
  • EPS
  • CELZ N/A
  • IMCC N/A
  • Revenue
  • CELZ $14,000.00
  • IMCC $37,894,737.00
  • Revenue This Year
  • CELZ N/A
  • IMCC $47.12
  • Revenue Next Year
  • CELZ N/A
  • IMCC $12.83
  • P/E Ratio
  • CELZ N/A
  • IMCC N/A
  • Revenue Growth
  • CELZ 55.56
  • IMCC 12.68
  • 52 Week Low
  • CELZ $1.69
  • IMCC $1.29
  • 52 Week High
  • CELZ $6.90
  • IMCC $6.74
  • Technical
  • Relative Strength Index (RSI)
  • CELZ 55.59
  • IMCC 93.29
  • Support Level
  • CELZ $1.93
  • IMCC $1.54
  • Resistance Level
  • CELZ $2.02
  • IMCC $2.10
  • Average True Range (ATR)
  • CELZ 0.10
  • IMCC 0.70
  • MACD
  • CELZ 0.03
  • IMCC 0.43
  • Stochastic Oscillator
  • CELZ 86.21
  • IMCC 89.69

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: